Matches in Nanopublications for { ?s ?p "[Thirty-five of 49 (71.4 percent) serrated adenomas exhibited moderate to intense cyclooxygenase-2 immunoreactivity, and 8 of 25 hyperplastic polyps (32 percent) showed weak to moderate cyclooxygenase-2 immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_assertion description "[Thirty-five of 49 (71.4 percent) serrated adenomas exhibited moderate to intense cyclooxygenase-2 immunoreactivity, and 8 of 25 hyperplastic polyps (32 percent) showed weak to moderate cyclooxygenase-2 immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657968.RASc9VEHPyu-DSFvAB3UaqKU1YjaQxbV6K-J-5LOCsT7U130_provenance.
- assertion description "[Thirty-five of 49 (71.4 percent) serrated adenomas exhibited moderate to intense cyclooxygenase-2 immunoreactivity, and 8 of 25 hyperplastic polyps (32 percent) showed weak to moderate cyclooxygenase-2 immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_assertion description "[Thirty-five of 49 (71.4 percent) serrated adenomas exhibited moderate to intense cyclooxygenase-2 immunoreactivity, and 8 of 25 hyperplastic polyps (32 percent) showed weak to moderate cyclooxygenase-2 immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_provenance.